½ÃÀ庸°í¼­
»óǰÄÚµå
1762255

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : ±â¼ú, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)

Microbiome Sequencing Services Market Size, Share, Trends, Industry Analysis Report: By Technology, Application, End Use, and Region - Market Forecast, 2025-2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ¼¼°è ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 46¾ï 5,410¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º´Â 16S rRNA À¯ÀüÀÚ ½ÃÄö½Ì, ¼¦°Ç ¸ÞŸÀ¯Àüü, ¸ÞŸƮ·£½ºcriptomics µî ÷´Ü ½ÃÄö½Ì ±â¼úÀ» ÅëÇÑ ¹Ì»ý¹° ±ºÁý ºÐ¼®À» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â Àΰ£ÀÇ Àå, ÇǺÎ, Åä¾ç, ¹° µî ´Ù¾çÇÑ È¯°æ¿¡¼­ ¹Ì»ý¹°ÀÇ µ¿Á¤ ¹× Ư¼º ºÐ¼®¿¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¹Ì»ý¹°ÀÇ ´Ù¾ç¼º°ú ±â´ÉÀû ¿ªÇÒ¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÔÀ¸·Î½á ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½ÌÀº Áúº´ ¿¬±¸, ¸ÂÃã ÀÇ·á, ÀǾàǰ °³¹ß, ³ó¾÷, ȯ°æ ¿¬±¸¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀåÀÇ ¼ºÀåÀº Àΰ£ÀÇ °Ç°­°ú Áúº´¿¡¼­ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿ÈÀÇ ¿ªÇÒ¿¡ ´ëÇÑ ¿¬±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) ±â¼úÀÇ ¹ßÀü, Á¤ºÎ ±â°ü ¹× ¹Î°£ ´ÜüÀÇ ÅõÀÚ Áõ°¡, Áúº´ Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ Àû¿ë È®´ë µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÂÃãÇü ÀÇ·á, ÇÁ·Î¹ÙÀÌ¿Àƽ½º, ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ±â¹Ý ÀǾàǰ °³¹ß¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â AI¸¦ Ȱ¿ëÇÑ ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º, Àü·«Àû Á¦ÈÞ, °³¹ßµµ»ó±¹ ¼­ºñ½º È®´ë µî ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½ºÀÇ »õ·Î¿î ½ÃÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï±¹ ½ÃÀå µ¿ÇâÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ¿¬±¸°¡ ÇコÄɾî, ³ó¾÷, ȯ°æ°úÇÐ ºÐ¾ß¿¡¼­ Áö¼ÓÀûÀ¸·Î Á߿伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÄö½Ì ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä´Â ¿¹Ãø ±â°£ µ¿¾È È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

±â¼úº°·Î º¸¸é ÇÕ¼º ½ÃÄö½Ì ºÎ¹®Àº ³ôÀº Á¤È®µµ, ºñ¿ë È¿À²¼º, Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) Ç÷§ÆûÀÇ ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ¸·Î ÀÎÇØ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ¼öÀÍ¿¡¼­ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î´Â ¼ÒÈ­±â Áúȯ ºÐ¾ß°¡ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ¼ÒÈ­±â °Ç°­ À¯Áö¿¡ ÀÖ¾î Àå³» ¹Ì»ý¹°ÀÇ Áß¿äÇÑ ¿ªÇÒ°ú ´Ù¾çÇÑ ¼ÒÈ­±â Áúȯ°úÀÇ ¿¬°ü¼º¿¡ ±âÀÎÇÕ´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ¼¼°è ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí Àִµ¥, ÀÌ´Â ÁÖ·Î ÇコÄɾî ÀÎÇÁ¶ó°¡ Àß ±¸ÃàµÇ¾î ÀÖ°í, À¯ÀüüÇÐ ¹× ¹Ì»ý¹°ÇÐ ¿¬±¸°³¹ß Ȱµ¿ÀÌ È°¹ßÇϱ⠶§¹®ÀÔ´Ï´Ù.

À¯·´ÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀåÀº À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¼¿ÇÁ ¸ÞµðÄÉÀ̼ǿ¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ Å« ÆøÀÇ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀå¿¡´Â ¼ºÀå°ú Çõ½Å¿¡ ±â¿©ÇÏ´Â ¿©·¯ ÁÖ¿ä ±â¾÷µéÀÌ È°¹ßÇÏ°Ô È°µ¿Çϰí ÀÖ½À´Ï´Ù. ÁÖ¸ñÇÒ ¸¸ÇÑ ±â¾÷À¸·Î´Â Baseclear B.V., Clinical Microbiomics A/S., Merieux NutriSciences Corporation, Metabiomics Corp. Microbiome Therapeutics, LLC, Molzym GmbH & Co.KG, MR DNA, Resphera Biosciences, LLC, Zymo Research Corporation µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ÇöȲ
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
      • ½ÃÄö½Ì ±â¼úÀÇ Áøº¸
      • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀÚ±Ý
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
      • ½ÃÄö½Ì°ú µ¥ÀÌÅÍ ºÐ¼®ÀÇ °íºñ¿ë
  • PESTEL ºÐ¼®
  • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ¾ÖÇø®ÄÉÀÌ¼Ç µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå : ±â¼úº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ÇÕ¼º¿¡ ÀÇÇÑ ¹è¿­ °áÁ¤
  • °áÂû¿¡ ÀÇÇÑ ¹è¿­ °áÁ¤
  • »ý¾î ½ÃÄö½Ì
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå : ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • ÀÚ°¡¸é¿ªÁúȯ
  • ¾Ï
  • À§ÀåÀå¾Ö
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • Çмú¿¬±¸±â°ü
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼Ò°³
    • ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È ½ÃÄö½Ì ¼­ºñ½º ½ÃÀå ºÐ¼® : Áö¿ªº°, 2020-2034³â
  • ºÏ¹Ì
    • ºÏ¹Ì : ±â¼úº°, 2020-2034³â
    • ºÏ¹Ì : ¿ëµµº°, 2020-2034³â
    • ºÏ¹Ì : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • À¯·´ : ±â¼úº°, 2020-2034³â
    • À¯·´ : ¿ëµµº°, 2020-2034³â
    • À¯·´ : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³×´ú¶õµå
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±â¼úº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ¿ëµµº°, 2020-2034³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • Áß±¹
    • Àεµ
    • ¸»·¹À̽þÆ
    • ÀϺ»
    • Àεµ³×½Ã¾Æ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±â¼úº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÃÖÁ¾ ¿ëµµº°, 2020-2034³â
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±â¼úº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ¿ëµµº°, 2020-2034³â
    • ¸ß½ÃÄÚ
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • È®´ë¿Í Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • Baseclear B.V.
  • BioSpherex LLC
  • Clinical Microbiomics A/S
  • Merieux NutriSciences Corporation
  • Metabiomics Corp.
  • Microbiome Insights Inc.
  • Microbiome Therapeutics, LLC.
  • Molzym GmbH & Co. KG
  • MR DNA
  • Phase Genomics
ksm 25.07.09

The global microbiome sequencing services market size is expected to reach USD 4,654.10 million by 2034, according to a new study by Polaris Market Research. The report "Microbiome Sequencing Services Market Size, Share, Trends, Industry Analysis Report: By Technology (Sequencing by Synthesis, Sequencing by Ligation, Sanger Sequencing, and Others), Application, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Microbiome sequencing services involve the analysis of microbial communities through advanced sequencing technologies, including 16S rRNA gene sequencing, shotgun metagenomics, and metatranscriptomics. These services are widely used to identify and characterize microorganisms in various environments, such as the human gut, skin, soil, and water. By providing insights into microbial diversity and functional roles, microbiome sequencing plays a crucial role in disease research, personalized medicine, drug development, agriculture, and environmental studies.

The microbiome sequencing services market growth is attributed to increasing research on the role of microbiomes in human health and disease. Key drivers include advancements in next-generation sequencing (NGS) technologies, rising investments from government and private organizations, and growing applications in disease diagnostics and therapeutics. Additionally, the increasing demand for personalized medicine, probiotics, and microbiome-based drug development presents new market opportunities. Emerging microbiome sequencing services market trends such as AI-driven bioinformatics, strategic collaborations, and service expansion in developing regions are further supporting market expansion. As microbiome research continues to gain importance in healthcare, agriculture, and environmental sciences, the demand for sequencing services is expected to grow during the forecast period.

Microbiome Sequencing Services Market Report Highlights

By technology, the sequencing by synthesis segment holds the largest share of the microbiome sequencing services market revenue due to its high accuracy, cost efficiency, and widespread adoption in next-generation sequencing (NGS) platforms.

By application, the gastrointestinal disorders segment holds the largest market share in 2024. This prominence is attributed to the critical role of the gut microbiome in maintaining digestive health and its association with various gastrointestinal diseases.

By region, North America holds the largest share of the global microbiome sequencing services market, primarily due to its well-established healthcare infrastructure and significant research and development activities in genomics and microbiology.

The Europe microbiome sequencing services market is experiencing significant growth, driven by the increasing prevalence of genetic disorders and a rising preference for self-medication.

The market features several active key players contributing to its growth and innovation. Notable companies include Baseclear B.V.; Clinical Microbiomics A/S; Merieux NutriSciences Corporation; Metabiomics Corp.; Microbiome Insights Inc.; Microbiome Therapeutics, LLC; Molzym GmbH & Co. KG; MR DNA; Resphera Biosciences, LLC; Zymo Research Corporation; and others.

Polaris Market Research has segmented the microbiome sequencing services market report on the basis of technology, application, end use, and region:

By Technology Outlook (Revenue - USD Million, 2020-2034)

Sequencing by Synthesis

Sequencing by Ligation

Sanger Sequencing

Others

By Application Outlook (Revenue - USD Million, 2020-2034)

Autoimmune Disorder

Cancer

Gastrointestinal Disorders

Others

By End Use Outlook (Revenue - USD Million, 2020-2034)

Pharmaceutical & Biotechnology Companies

Academic Research Institutes

Others

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Microbiome Sequencing Services Market Insights

  • 4.1. Microbiome Sequencing Services Market - Market Snapshot
  • 4.2. Microbiome Sequencing Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in sequencing technologies
      • 4.2.1.2. Government initiatives and funding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Sequencing and Data Analysis
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Microbiome Sequencing Services Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Microbiome Sequencing Services Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
  • 5.3. Sequencing by synthesis
    • 5.3.1. Global Microbiome Sequencing Services Market, by Sequencing by synthesis, by Region, 2020-2034 (USD Million)
  • 5.4. Sequencing by ligation
    • 5.4.1. Global Microbiome Sequencing Services Market, by Sequencing by ligation, by Region, 2020-2034 (USD Million)
  • 5.5. Sanger sequencing
    • 5.5.1. Global Microbiome Sequencing Services Market, by Sanger sequencing, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Microbiome Sequencing Services Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Microbiome Sequencing Services Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 6.3. Autoimmune Disorder
    • 6.3.1. Global Microbiome Sequencing Services Market, by Autoimmune Disorder, by Region, 2020-2034 (USD Million)
  • 6.4. Cancer
    • 6.4.1. Global Microbiome Sequencing Services Market, by Cancer, by Region, 2020-2034 (USD Million)
  • 6.5. Gastrointestinal Disorders
    • 6.5.1. Global Microbiome Sequencing Services Market, by Gastrointestinal Disorders, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Microbiome Sequencing Services Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Microbiome Sequencing Services Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 7.3. Pharmaceutical & biotechnology companies
    • 7.3.1. Global Microbiome Sequencing Services Market, by Pharmaceutical & biotechnology companies, by Region, 2020-2034 (USD Million)
  • 7.4. Academic research institutes
    • 7.4.1. Global Microbiome Sequencing Services Market, by Academic research institutes, by Region, 2020-2034 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Microbiome Sequencing Services Market, by Others, by Region, 2020-2034 (USD Million)

8. Global Microbiome Sequencing Services Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Microbiome Sequencing Services Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Microbiome Sequencing Services Market - North America
    • 8.3.1. North America: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.3.2. North America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.3.4. Microbiome Sequencing Services Market - U.S.
      • 8.3.4.1. U.S.: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.3.5. Microbiome Sequencing Services Market - Canada
      • 8.3.5.1. Canada: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 8.4. Microbiome Sequencing Services Market - Europe
    • 8.4.1. Europe: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.4.2. Europe: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.4. Microbiome Sequencing Services Market - UK
      • 8.4.4.1. UK: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.5. Microbiome Sequencing Services Market - France
      • 8.4.5.1. France: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.5.2. France: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.6. Microbiome Sequencing Services Market - Germany
      • 8.4.6.1. Germany: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.7. Microbiome Sequencing Services Market - Italy
      • 8.4.7.1. Italy: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.8. Microbiome Sequencing Services Market - Spain
      • 8.4.8.1. Spain: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.9. Microbiome Sequencing Services Market - Netherlands
      • 8.4.9.1. Netherlands: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.10. Microbiome Sequencing Services Market - Russia
      • 8.4.10.1. Russia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.4.11. Microbiome Sequencing Services Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 8.5. Microbiome Sequencing Services Market - Asia Pacific
    • 8.5.1. Asia Pacific: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.4. Microbiome Sequencing Services Market - China
      • 8.5.4.1. China: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.4.2. China: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.5. Microbiome Sequencing Services Market - India
      • 8.5.5.1. India: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.5.2. India: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.6. Microbiome Sequencing Services Market - Malaysia
      • 8.5.6.1. Malaysia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.7. Microbiome Sequencing Services Market - Japan
      • 8.5.7.1. Japan: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.8. Microbiome Sequencing Services Market - Indonesia
      • 8.5.8.1. Indonesia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.9. Microbiome Sequencing Services Market - South Korea
      • 8.5.9.1. South Korea: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.10. Microbiome Sequencing Services Market - Australia
      • 8.5.10.1. Australia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.5.11. Microbiome Sequencing Services Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 8.6. Microbiome Sequencing Services Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.4. Microbiome Sequencing Services Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.5. Microbiome Sequencing Services Market - UAE
      • 8.6.5.1. UAE: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.6. Microbiome Sequencing Services Market - Israel
      • 8.6.6.1. Israel: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.7. Microbiome Sequencing Services Market - South Africa
      • 8.6.7.1. South Africa: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.6.8. Microbiome Sequencing Services Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
  • 8.7. Microbiome Sequencing Services Market - Latin America
    • 8.7.1. Latin America: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.4. Microbiome Sequencing Services Market - Mexico
      • 8.7.4.1. Mexico: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.5. Microbiome Sequencing Services Market - Brazil
      • 8.7.5.1. Brazil: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.6. Microbiome Sequencing Services Market - Argentina
      • 8.7.6.1. Argentina: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
    • 8.7.7. Microbiome Sequencing Services Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Microbiome Sequencing Services Market, by Technology, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Microbiome Sequencing Services Market, by Application, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Baseclear B.V.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BioSpherex LLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Clinical Microbiomics A/S
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Merieux NutriSciences Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Metabiomics Corp.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Microbiome Insights Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Microbiome Therapeutics, LLC.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Molzym GmbH & Co. KG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. MR DNA
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Phase Genomics
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦